Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2005 Jun 07;10223:8233-8. doi: 10.1073/pnas.0502885102.
Show Gene links
Show Anatomy links
Distinct effectors of platelet-derived growth factor receptor-alpha signaling are required for cell survival during embryogenesis.
Van Stry M
,
Kazlauskas A
,
Schreiber SL
,
Symes K
.
Abstract
Platelet-derived growth factor receptor (PDGFR) signaling is essential for normal embryonic development in many organisms, including frog, mouse, zebrafish, and sea urchin. The mode of action of PDGFR signaling during early development is poorly understood, however, mostly because inhibition of signaling through either the PDGFRalpha or PDGFRbeta is embryonic lethal. In Xenopus embryos, disruption of PDGFRalpha signaling causes migrating anteriormesoderm cells to lose direction and undergo apoptosis through the mitochondrial pathway. To understand the mechanism of PDGFRalpha function in this process, we have analyzed all known effector-binding sites in vivo. By using a chemical inducer of dimerization to activate chimera PDGFRalphas, we have identified a role for phospholipase Cgamma (PLCgamma) in protecting cells from death. PDGFRalpha-mediated cell survival requires PLCgamma and phosphatidylinositol 3-kinase signaling, and that PDGFRalpha with binding sites for these two signaling factors is sufficient for this activity. Other effectors of PDGFRalpha signaling, Shf, SHP-2, and Crk, are not required for this process. Thus, our findings show that PDGFRalpha signaling through PLCgamma and phosphatidylinositol 3-kinase has a protective role in preventing apoptosis in early development. Furthermore, we demonstrate that small molecule inducers of dimerization provide a powerful system to manipulate receptor function in developing embryos.
Fig. 1. Schematic of iPDGFRα mutants. To dissect PDGFRα signaling, tyrosines that when phosphorylated (P) bind and activate specific downstream effectors were replaced by phenylalanine (black squares) by site-directed mutagenesis. (A) Subtraction mutants contain mutations that allow binding and activation of all but one downstream effector. (B) Add-back mutants contain mutations to allow binding and activation of one or more downstream effector. (C) iPDGFRα is a fusion protein of the myristoylation signal from v-Src, three tandem repeats of FKBP12 containing point mutations G89P and I90K to block calcineurin binding, and the cytoplasmic domain of the PDGFRα with or without specific Y→F mutations. The addition of the dimerizer, AP1510, activates the receptor kinase through the induced dimerization of two of the receptor fusion proteins.
Fig. 2. PDGFR signaling through PLCγ and PI3K, but not through SHP-2, Shf, and Crk, is required for mesoderm cell survival. (A and B) Embryos were coinjected with mRNA encoding β-gal and iPDGFRα or β-gal, PDGFR-37 (R37), and the following iPDGFRαs. (C and D) wt. (E and F) F572/74. (G and H) F720. (I and J) F731/42. (K and L) F762. (M and N) F988. (O and P) F1018. At the beginning of gastrulation (stage 10), AP1510 or DMSO was injected into the blastocoel. At the midgastrula stage (stage 11), β-gal expression was visualized (shown in blue). The stained embryos were dissected and scored for the presence or absence of nonnuclear β-gal-stained cells in the blastocoel cavity, within the vitelline membrane, or in the process of being excluded from the embryo (see red arrowhead in K), indicating the presence of apoptotic cells. The percentage of embryos containing apoptotic cells was calculated. Representative saggital sections of these embryos are shown. (G–P) Note that when signaling through PLCγ and PI3K is prevented (I, J, and M–P), activation of the receptor with AP1510 did not restore cell survival, whereas cell survival is restored when signaling through SHP-2, Shf, and Crk is prevented (G, H, K, and L). Arrowheads indicate apoptotic mesoderm cells outside the blastocoel cavity. Note that overexpression of iPDGFRα-wt mRNA alone does not cause apoptosis in mesoderm cells.
Fig. 3. PDGFR signaling through a single downstream effector is not sufficient for mesoderm cell survival. (A and B) Embryos were coinjected with mRNA encoding β-gal and iPDGFRα or β-gal, PDGFR-37 (R37), and the following iPDGFRαs. (C and D) wt. (E and F) Y572/74. (G and H) Y720. (I and J) Y731/42. (K and L) Y762. (M and N) Y988. (O and P) Y1018. At the beginning of gastrulation (stage 10), AP1510 or DMSO was injected into the blastocoel. At the midgastrula stage (stage 11), β-gal expression was visualized (shown in blue). Representative saggital sections of these embryos are shown. (E–P) Note that single effectors do not restore cell survival. Arrowheads indicate apoptotic mesoderm cells outside the blastocoel cavity.
Fig. 4. PDGFR signaling through PLCγ and PI3K is required for mesoderm cell survival. (A and B) Embryos were coinjected with mRNA encoding β-gal and iPDGFRα or β-gal, PDGFR-37 (R37), and the following iPDGFRαs. (C and D) wt. (E and F) F720/762. (G and H) F4. At the beginning of gastrulation (stage 10), AP1510 or DMSO was injected into the blastocoel. At the midgastrula stage (stage 11), β-gal expression was visualized (shown in blue). Representative saggital sections of these embryos are shown. As shown in E and F, only the presence of PLCγ, PI3K, and Src pYBs are required to restore mesoderm cell survival.
Fig. 5. PDGFR signaling through PLCγ and PI3K is required for mesoderm cell survival. The data presented in Figs. 2, 3, 4 are shown in graph form. The percentage of embryos that do not contain apoptotic cells (i.e., cells with nonnuclear β-gal staining) is presented for embryos injected with mRNA as described in Figs. 2, 3, 4 and with DMSO (gray bars) or AP1510 (black bars). This percentage is low for some mutants compared with wt because there may be some basal activity of the receptor construct without the addition of dimerizer. Error bars represent standard error and were calculated from a minimum of three separate experiments. The data used to construct this graph is available in Table 1, which is published as supporting information on the PNAS web site.
Amara,
A versatile synthetic dimerizer for the regulation of protein-protein interactions.
1997, Pubmed
Amara,
A versatile synthetic dimerizer for the regulation of protein-protein interactions.
1997,
Pubmed
Ataliotis,
PDGF signalling is required for gastrulation of Xenopus laevis.
1995,
Pubmed
,
Xenbase
Baxter,
Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events.
1998,
Pubmed
Bazenet,
Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation.
1996,
Pubmed
Bell,
PLCgamma2 regulates Bcl-2 levels and is required for survival rather than differentiation of marginal zone and follicular B cells.
2004,
Pubmed
Carballada,
Phosphatidylinositol-3 kinase acts in parallel to the ERK MAP kinase in the FGF pathway during Xenopus mesoderm induction.
2001,
Pubmed
,
Xenbase
Dale,
Regional specification within the mesoderm of early embryos of Xenopus laevis.
1987,
Pubmed
,
Xenbase
Datta,
Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis.
2002,
Pubmed
DeMali,
Multiple roles for Src in a PDGF-stimulated cell.
1999,
Pubmed
Denoyelle,
Mesoderm-independent regulation of gastrulation movements by the src tyrosine kinase in Xenopus embryo.
2001,
Pubmed
,
Xenbase
Eriksson,
Demonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptors.
1995,
Pubmed
Feller,
Crk family adaptors-signalling complex formation and biological roles.
2001,
Pubmed
Franke,
PI3K/Akt and apoptosis: size matters.
2003,
Pubmed
Gelderloos,
A role for Src in signal relay by the platelet-derived growth factor alpha receptor.
1998,
Pubmed
Heldin,
Mechanism of action and in vivo role of platelet-derived growth factor.
1999,
Pubmed
Heldin,
Platelet-derived growth factor: mechanism of action and possible in vivo function.
1990,
Pubmed
Hoch,
Roles of PDGF in animal development.
2003,
Pubmed
,
Xenbase
Hooshmand-Rad,
PDGF alpha-receptor mediated cellular responses are not dependent on Src family kinases in endothelial cells.
1998,
Pubmed
Hubbard,
Juxtamembrane autoinhibition in receptor tyrosine kinases.
2004,
Pubmed
Ji,
Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development.
1997,
Pubmed
Katan,
Structural and mechanistic aspects of phospholipase Cgamma regulation.
2003,
Pubmed
Klinghoffer,
An allelic series at the PDGFalphaR locus indicates unequal contributions of distinct signaling pathways during development.
2002,
Pubmed
Klinghoffer,
Identification of a putative Syp substrate, the PDGF beta receptor.
1995,
Pubmed
Lane,
Rethinking axial patterning in amphibians.
2002,
Pubmed
,
Xenbase
Lindholm,
Shf, a Shb-like adapter protein, is involved in PDGF-alpha-receptor regulation of apoptosis.
2000,
Pubmed
McCall,
Requirement for DCP-1 caspase during Drosophila oogenesis.
1998,
Pubmed
Moody,
Fates of the blastomeres of the 16-cell stage Xenopus embryo.
1987,
Pubmed
,
Xenbase
Mori,
Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases.
1993,
Pubmed
Nagel,
Guidance of mesoderm cell migration in the Xenopus gastrula requires PDGF signaling.
2004,
Pubmed
,
Xenbase
Rameh,
Phosphoinositide 3-kinase regulates phospholipase Cgamma-mediated calcium signaling.
1998,
Pubmed
Rosenkranz,
Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis.
1999,
Pubmed
Soriano,
The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites.
1997,
Pubmed
Van Stry,
The mitochondrial-apoptotic pathway is triggered in Xenopus mesoderm cells deprived of PDGF receptor signaling during gastrulation.
2004,
Pubmed
,
Xenbase
Wen,
Phospholipase Cgamma2 provides survival signals via Bcl2 and A1 in different subpopulations of B cells.
2003,
Pubmed
Yang,
Small-molecule control of insulin and PDGF receptor signaling and the role of membrane attachment.
1998,
Pubmed
,
Xenbase
Yao,
Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor.
1995,
Pubmed
Yokote,
Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
1998,
Pubmed